United Laboratories International Holdings Stock | 3933.HK | KYG8813K1085 | A0MUFS

Date	United Laboratories International Holdings Price
10/18/2024	9.78 undefined
10/17/2024	9.31 undefined
10/16/2024	9.31 undefined
10/15/2024	9.40 undefined
10/14/2024	9.63 undefined
10/10/2024	9.98 undefined
10/9/2024	9.69 undefined
10/8/2024	9.68 undefined
10/7/2024	10.28 undefined
10/4/2024	9.92 undefined
10/3/2024	9.35 undefined
10/2/2024	9.55 undefined
9/30/2024	9.12 undefined
9/27/2024	8.79 undefined
9/26/2024	8.44 undefined
9/25/2024	8.03 undefined
9/24/2024	8.18 undefined
9/23/2024	7.75 undefined
9/20/2024	7.88 undefined

Date	United Laboratories International Holdings Revenue	United Laboratories International Holdings EBIT	United Laboratories International Holdings Net Income
2026e	16.33 B undefined	3.66 B undefined	3 B undefined
2025e	15.48 B undefined	3.5 B undefined	2.85 B undefined
2024e	14.94 B undefined	3.57 B undefined	2.88 B undefined
2023	13.74 B undefined	3.28 B undefined	2.7 B undefined
2022	11.33 B undefined	2.11 B undefined	1.58 B undefined
2021	9.7 B undefined	1.16 B undefined	988.1 M undefined
2020	8.77 B undefined	1.25 B undefined	702.99 M undefined
2019	8.39 B undefined	1.08 B undefined	641.76 M undefined
2018	7.51 B undefined	1.01 B undefined	682.93 M undefined
2017	6.83 B undefined	689.11 M undefined	81.76 M undefined
2016	6.08 B undefined	408.18 M undefined	-272.36 M undefined
2015	6.74 B undefined	741.62 M undefined	96.69 M undefined
2014	7.19 B undefined	1.29 B undefined	609.78 M undefined
2013	6.06 B undefined	409.2 M undefined	38.1 M undefined
2012	5.71 B undefined	315.8 M undefined	131.7 M undefined
2011	5.32 B undefined	276.1 M undefined	86.6 M undefined
2010	5.67 B undefined	1.08 B undefined	848.8 M undefined
2009	4.09 B undefined	706.4 M undefined	477.1 M undefined
2008	3.35 B undefined	559 M undefined	383.9 M undefined
2007	2.53 B undefined	613.6 M undefined	497.6 M undefined
2006	2.13 B undefined	305 M undefined	178.4 M undefined
2005	1.81 B undefined	243.4 M undefined	122.7 M undefined
2004	1.28 B undefined	212.6 M undefined	140.4 M undefined

	Revenue	EBIT	Net Income
2004	1.28 B CNY	212.6 M CNY	140.4 M CNY
2005	1.81 B CNY	243.4 M CNY	122.7 M CNY
2006	2.13 B CNY	305 M CNY	178.4 M CNY
2007	2.53 B CNY	613.6 M CNY	497.6 M CNY
2008	3.35 B CNY	559 M CNY	383.9 M CNY
2009	4.09 B CNY	706.4 M CNY	477.1 M CNY
2010	5.67 B CNY	1.08 B CNY	848.8 M CNY
2011	5.32 B CNY	276.1 M CNY	86.6 M CNY
2012	5.71 B CNY	315.8 M CNY	131.7 M CNY
2013	6.06 B CNY	409.2 M CNY	38.1 M CNY
2014	7.19 B CNY	1.29 B CNY	609.78 M CNY
2015	6.74 B CNY	741.62 M CNY	96.69 M CNY
2016	6.08 B CNY	408.18 M CNY	-272.36 M CNY
2017	6.83 B CNY	689.11 M CNY	81.76 M CNY
2018	7.51 B CNY	1.01 B CNY	682.93 M CNY
2019	8.39 B CNY	1.08 B CNY	641.76 M CNY
2020	8.77 B CNY	1.25 B CNY	702.99 M CNY
2021	9.7 B CNY	1.16 B CNY	988.1 M CNY
2022	11.33 B CNY	2.11 B CNY	1.58 B CNY
2023	13.74 B CNY	3.28 B CNY	2.7 B CNY
2024e	14.94 B CNY	3.57 B CNY	2.88 B CNY
2025e	15.48 B CNY	3.5 B CNY	2.85 B CNY
2026e	16.33 B CNY	3.66 B CNY	3 B CNY

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.11	0.16	0.1	0.38	0.15	0.17	0.39	0.77	0.52	0.84	0.9	0.98	1.78	1.59	1.58	3.16	3	3.33	4.74	4.26
0.43	0.66	0.75	0.76	0.96	1.47	1.92	1.65	1.75	2.13	2.29	1.71	1.76	2.27	2.96	2.56	2.74	3.42	4.46	6.31
369	339	567	86	94	161	259	383	584	437	378	217	202.64	182.8	108.18	684.13	615.38	376.25	447.57	0
0.17	0.29	0.35	0.52	0.68	0.78	1.06	1.25	1.46	0.99	1.27	1.24	0.96	1.17	1.46	1.58	1.43	2	2.16	2.24
0.01	0.14	0.22	0.33	0.26	0.26	0.33	0.48	1.01	0.7	1.09	0.91	1.05	0.54	0.59	0.73	0.44	0.85	0.7	0.97
1.09	1.57	1.99	2.07	2.14	2.84	3.96	4.53	5.32	5.11	5.93	5.05	5.76	5.76	6.7	8.71	8.22	9.99	12.51	13.79
1.41	1.77	1.65	2.27	3.17	3.59	4.06	4.93	7.38	8.02	8.78	8.16	7.38	6.87	6.54	6.49	6.39	6.13	6.27	7
0	0	0	0	0	0	0	0	0	1.81	1.46	1.3	1.12	0.79	0.7	0	0	0	0.01	0.01
25	28	7	0	0	0	0	0	0	0	0	0	0	0	0	276.36	105.68	0	0	0
110	7	4	5	3	5	3	2	2	47	48.81	84.1	144.19	150.8	141.34	137.18	131.28	119.83	100.34	133.96
1	3	3	3	3	3	3	3	3	3	3.38	3.16	3.03	3.03	3.03	3.03	3.03	3.03	3.03	3.03
12	87	81	102	122	132	125	151	274	314	714.94	653.64	563.88	531.54	521.72	82.55	109.52	90.04	87.29	80.8
1.56	1.89	1.74	2.38	3.29	3.73	4.19	5.09	7.66	10.2	11.01	10.2	9.21	8.35	7.91	6.99	6.74	6.34	6.46	7.23
2.65	3.47	3.73	4.45	5.43	6.57	8.15	9.62	12.98	15.3	16.94	15.25	14.97	14.11	14.6	15.7	14.96	16.33	18.98	21.02

0	0	0	11	11	11	11	11	13	13	14.57	14.25	15.24	15.24	15.35	15.36	17.18	17.13	16.97	16.97
0	0	0	0.72	0.68	0.68	1.66	1.59	2.14	2.07	2.38	2.33	2.36	2.36	2.44	2.45	3.81	3.78	3.72	0
0.94	1.05	1.32	1.39	1.5	1.82	2.25	2.02	2.13	2.11	3.02	3.06	2.89	2.97	3.57	4.21	4.78	5.55	6.86	12.72
0	0	0	179	290	303	410	583	623	774	714.27	382.83	-9.86	2.66	3.27	1.3	7.21	7.68	9.11	0
0	0	0	0	0	0	0	0	0	95	109.2	106.86	95.62	95.62	95.62	0	0	0	0	0
0.94	1.05	1.32	2.3	2.48	2.81	4.33	4.2	4.9	5.06	6.24	5.89	5.35	5.44	6.12	6.67	8.61	9.36	10.61	12.73
0.47	0.87	0.78	0.57	0.93	1.25	1.3	1.27	1.45	3.34	3.2	2.89	2.93	3.27	3.7	2.28	2.28	3.21	3.56	6.05
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	539.95	672.55	797.29	0
0.03	0.03	0.15	0.28	0.43	0.51	0.44	0.61	1.32	0.03	0.08	0.21	0.17	0.1	0.15	1.6	1.13	1.04	1.31	0.37
5	8	7	3	4	1	753	0	0	0	0	0	0	0	96.64	0	0	0	0	0
0.57	0.94	1.05	0.78	1.19	1.19	1.24	2.5	4.43	4.33	4.7	4.32	3.63	1.42	2.57	2.58	0.91	1.61	1.36	0.2
1.08	1.84	1.98	1.63	2.55	2.94	3.73	4.38	7.2	7.7	7.98	7.41	6.73	4.79	6.52	6.46	4.86	6.54	7.03	6.63
0.52	0.44	0.41	0.51	0.37	0.76	0	0.76	0.82	1.69	1.94	1.24	2.25	3.43	1.59	2.42	1.3	0.23	1.1	1.3
18	17	16	13	31	61	81	61	52	768	687.72	624.72	576.58	362.67	296.87	77.8	119.58	172.31	194.07	288.08
0	0	0	0	0	0	0	211	0	84	92.5	85.95	62.79	84.95	77.45	68.09	69.92	55.32	43.41	51.43
0.53	0.45	0.43	0.52	0.41	0.82	0.08	1.04	0.87	2.54	2.72	1.95	2.89	3.88	1.97	2.57	1.49	0.46	1.34	1.64
1.61	2.3	2.41	2.15	2.95	3.76	3.81	5.42	8.08	10.24	10.7	9.37	9.62	8.67	8.48	9.03	6.35	6.99	8.37	8.27
2.55	3.35	3.73	4.45	5.43	6.57	8.15	9.62	12.98	15.3	16.94	15.25	14.97	14.11	14.6	15.7	14.97	16.35	18.98	21

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0.19	0.18	0.23	0.54	0.48	0.61	1.01	0.15	0.2	0.71	0.61	0.2	-0.14	0.07	0.79	0.84	0.88	1.2	2.01
90	119	196	179	223	295	362	377	436	451	647	687	710	784	741	675	614	620	552
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-80	-161	-215	-458	-161	-336	-870	-276	-271	260	-2	187	71	-554	-551	9	-226	-495	-587
34	70	84	85	81	83	76	168	113	-254	425	455	429	471	230	274	297	214	58
30	66	75	73	104	93	100	145	253	348	432	308	281	223	203	215	124	50	75
39	48	55	70	51	83	144	115	86	92	155	139	137	192	190	158	154	236	299
0.23	0.21	0.29	0.35	0.62	0.65	0.58	0.42	0.48	1.17	1.68	1.53	1.07	0.77	1.21	1.8	1.57	1.54	2.03
-546	-417	-150	-803	-1,004	-755	-948	-1,031	-2,320	-1,622	-640	-652	-403	-458	-477	-384	-530	-482	-818
-708	-466	-449	-845	-931	-751	-1,006	-1,172	-2,839	-1,251	-1,053	-317	-527	87	-555	-433	166	-587	-594
-162	-48	-299	-42	73	4	-58	-141	-518	370	-413	335	-124	545	-77	-49	697	-105	223
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.34	0.29	0.1	0	0.28	0.37	0.06	1.55	1.8	0.84	-0.18	-0.72	0.54	-0.87	-0.53	0.63	-1.66	-0.32	0.32
0	0	0	0.8	0	0	1.05	0	0.58	0	0	0	0	0	0	0	0	-0.04	-0.04
0.34	0.29	0.1	0.77	0.1	0.12	0.66	1.14	2.11	0.41	-0.68	-1.08	0.29	-1.04	-0.77	0.32	-1.91	-0.62	-0.02
-	-	-	-43.00	-	-93.00	-115.00	-178.00	-268.00	-428.00	-501.00	-360.00	-252.00	-171.00	-151.00	-215.00	-122.00	-41.00	-33.00
0	0	0	0	-182	-158	-337	-226	0	0	0	0	0	0	-84	-98	-128	-220	-272
-0.14	0.04	-0.06	0.3	-0.21	0.03	0.24	0.4	-0.25	0.34	-0.07	0.09	0.85	-0.19	-0.11	1.68	-0.17	0.33	1.41
-314.4	-205.5	142.1	-452	-385.8	-101.6	-365.9	-608.9	-1,840.3	-449.4	1,036.74	876.78	670.77	311.83	735.67	1,417.15	1,037.07	1,060.38	1,212.08
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

United Laboratories International Holdings Gross margin	United Laboratories International Holdings Profit margin	United Laboratories International Holdings EBIT margin	United Laboratories International Holdings Profit margin
2026e	46.11 %	22.41 %	18.4 %
2025e	46.11 %	22.62 %	18.43 %
2024e	46.11 %	23.87 %	19.25 %
2023	46.11 %	23.89 %	19.66 %
2022	43.84 %	18.58 %	13.95 %
2021	43.4 %	11.95 %	10.18 %
2020	43.39 %	14.26 %	8.01 %
2019	43.15 %	12.87 %	7.65 %
2018	40.64 %	13.39 %	9.09 %
2017	36.6 %	10.09 %	1.2 %
2016	35.58 %	6.72 %	-4.48 %
2015	38.48 %	11 %	1.43 %
2014	40.2 %	17.97 %	8.48 %
2013	34.49 %	6.75 %	0.63 %
2012	30.15 %	5.53 %	2.31 %
2011	28.55 %	5.19 %	1.63 %
2010	39.49 %	18.98 %	14.98 %
2009	39.07 %	17.26 %	11.66 %
2008	38.06 %	16.68 %	11.45 %
2007	46.47 %	24.26 %	19.67 %
2006	35.39 %	14.29 %	8.36 %
2005	34.86 %	13.43 %	6.77 %
2004	33.21 %	16.67 %	11.01 %

	Gross margin	EBIT margin	Profit margin
2004	33.21 %	16.67 %	11.01 %
2005	34.86 %	13.43 %	6.77 %
2006	35.39 %	14.29 %	8.36 %
2007	46.47 %	24.26 %	19.67 %
2008	38.06 %	16.68 %	11.45 %
2009	39.07 %	17.26 %	11.66 %
2010	39.49 %	18.98 %	14.98 %
2011	28.55 %	5.19 %	1.63 %
2012	30.15 %	5.53 %	2.31 %
2013	34.49 %	6.75 %	0.63 %
2014	40.2 %	17.97 %	8.48 %
2015	38.48 %	11 %	1.43 %
2016	35.58 %	6.72 %	-4.48 %
2017	36.6 %	10.09 %	1.2 %
2018	40.64 %	13.39 %	9.09 %
2019	43.15 %	12.87 %	7.65 %
2020	43.39 %	14.26 %	8.01 %
2021	43.4 %	11.95 %	10.18 %
2022	43.84 %	18.58 %	13.95 %
2023	46.11 %	23.89 %	19.66 %
2024e	46.11 %	23.87 %	19.25 %
2025e	46.11 %	22.62 %	18.43 %
2026e	46.11 %	22.41 %	18.4 %

Date	United Laboratories International Holdings Sales per Share	United Laboratories International Holdings EBIT per share	United Laboratories International Holdings Earnings per Share
2026e	8.99 undefined	0 undefined	1.65 undefined
2025e	8.52 undefined	0 undefined	1.57 undefined
2024e	8.22 undefined	0 undefined	1.58 undefined
2023	7.56 undefined	1.81 undefined	1.49 undefined
2022	6.23 undefined	1.16 undefined	0.87 undefined
2021	5.27 undefined	0.63 undefined	0.54 undefined
2020	4.97 undefined	0.71 undefined	0.4 undefined
2019	5.12 undefined	0.66 undefined	0.39 undefined
2018	4.09 undefined	0.55 undefined	0.37 undefined
2017	4.2 undefined	0.42 undefined	0.05 undefined
2016	3.74 undefined	0.25 undefined	-0.17 undefined
2015	4.14 undefined	0.46 undefined	0.06 undefined
2014	4.42 undefined	0.79 undefined	0.37 undefined
2013	3.73 undefined	0.25 undefined	0.02 undefined
2012	3.77 undefined	0.21 undefined	0.09 undefined
2011	3.7 undefined	0.19 undefined	0.06 undefined
2010	4.17 undefined	0.79 undefined	0.63 undefined
2009	3.13 undefined	0.54 undefined	0.36 undefined
2008	2.56 undefined	0.43 undefined	0.29 undefined
2007	2.18 undefined	0.53 undefined	0.43 undefined
2006	2.18 undefined	0.31 undefined	0.18 undefined
2005	1.85 undefined	0.25 undefined	0.13 undefined
2004	1.3 undefined	0.22 undefined	0.14 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	1.3 CNY	0.22 CNY	0.14 CNY
2005	1.85 CNY	0.25 CNY	0.13 CNY
2006	2.18 CNY	0.31 CNY	0.18 CNY
2007	2.18 CNY	0.53 CNY	0.43 CNY
2008	2.56 CNY	0.43 CNY	0.29 CNY
2009	3.13 CNY	0.54 CNY	0.36 CNY
2010	4.17 CNY	0.79 CNY	0.63 CNY
2011	3.7 CNY	0.19 CNY	0.06 CNY
2012	3.77 CNY	0.21 CNY	0.09 CNY
2013	3.73 CNY	0.25 CNY	0.02 CNY
2014	4.42 CNY	0.79 CNY	0.37 CNY
2015	4.14 CNY	0.46 CNY	0.06 CNY
2016	3.74 CNY	0.25 CNY	-0.17 CNY
2017	4.2 CNY	0.42 CNY	0.05 CNY
2018	4.09 CNY	0.55 CNY	0.37 CNY
2019	5.12 CNY	0.66 CNY	0.39 CNY
2020	4.97 CNY	0.71 CNY	0.4 CNY
2021	5.27 CNY	0.63 CNY	0.54 CNY
2022	6.23 CNY	1.16 CNY	0.87 CNY
2023	7.56 CNY	1.81 CNY	1.49 CNY
2024e	8.22 CNY	0 CNY	1.58 CNY
2025e	8.52 CNY	0 CNY	1.57 CNY
2026e	8.99 CNY	0 CNY	1.65 CNY

	Number of stocks
2004	980.5 M Aktien
2005	980.5 M Aktien
2006	980.5 M Aktien
2007	1.16 B Aktien
2008	1.31 B Aktien
2009	1.31 B Aktien
2010	1.36 B Aktien
2011	1.44 B Aktien
2012	1.51 B Aktien
2013	1.63 B Aktien
2014	1.63 B Aktien
2015	1.63 B Aktien
2016	1.63 B Aktien
2017	1.63 B Aktien
2018	1.83 B Aktien
2019	1.64 B Aktien
2020	1.77 B Aktien
2021	1.84 B Aktien
2022	1.82 B Aktien
2023	1.82 B Aktien
2024e	1.82 B Aktien
2025e	1.82 B Aktien
2026e	1.82 B Aktien

Date	United Laboratories International Holdings Dividend
2026e	0.32 undefined
2025e	0.32 undefined
2024e	0.32 undefined
2023	0.28 undefined
2022	0.15 undefined
2021	0.14 undefined
2020	0.08 undefined
2019	0.07 undefined
2018	0.06 undefined
2011	0.19 undefined
2010	0.28 undefined
2009	0.14 undefined
2008	0.16 undefined

	Dividend	Dividend (Estimate)
2004	0 CNY	0 CNY
2005	0 CNY	0 CNY
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0.16 CNY	0 CNY
2009	0.14 CNY	0 CNY
2010	0.28 CNY	0 CNY
2011	0.19 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0 CNY	0 CNY
2015	0 CNY	0 CNY
2016	0 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0.06 CNY	0 CNY
2019	0.07 CNY	0 CNY
2020	0.08 CNY	0 CNY
2021	0.14 CNY	0 CNY
2022	0.15 CNY	0 CNY
2023	0.28 CNY	0 CNY
2024e	0 CNY	0.32 CNY
2025e	0 CNY	0.32 CNY
2026e	0 CNY	0.32 CNY

Date	United Laboratories International Holdings Payout ratio
2026e	21.02 %
2025e	20.09 %
2024e	21.81 %
2023	21.17 %
2022	17.28 %
2021	26.98 %
2020	19.25 %
2019	17.44 %
2018	16.57 %
2017	21.17 %
2016	21.17 %
2015	21.17 %
2014	21.17 %
2013	21.17 %
2012	21.17 %
2011	321.25 %
2010	45.16 %
2009	38.24 %
2008	53.81 %
2007	21.17 %
2006	21.17 %
2005	21.17 %
2004	21.17 %

	Payout ratio
2004	21.17 %
2005	21.17 %
2006	21.17 %
2007	21.17 %
2008	53.81 %
2009	38.24 %
2010	45.16 %
2011	321.25 %
2012	21.17 %
2013	21.17 %
2014	21.17 %
2015	21.17 %
2016	21.17 %
2017	21.17 %
2018	16.57 %
2019	17.44 %
2020	19.25 %
2021	26.98 %
2022	17.28 %
2023	21.17 %
2024e	21.81 %
2025e	20.09 %
2026e	21.02 %

Date	EPS Estimate	EPS Actual	Quarterly report
6/30/2024	0.78	0.82 (5.78 %)	2024 Q2
12/31/2023	0.74	0.78 (4.75 %)	2023 Q4
6/30/2023	0.36	0.71 (98.04 %)	2023 Q2
12/31/2022	0.29	0.52 (83.12 %)	2022 Q4
6/30/2022	0.29	0.35 (21.15 %)	2022 Q2
12/31/2021	0.31	0.2 (-35.29 %)	2021 Q4
6/30/2021	0.27	0.34 (27.83 %)	2021 Q2
12/31/2020	0.31	0.28 (-9.15 %)	2020 Q4
6/30/2020	0.24	0.12 (-50.98 %)	2020 Q2
12/31/2019	0.17	0.19 (11.3 %)	2019 Q4
12/31/2018	0.13	0.08 (-39.94 %)	2018 Q4
6/30/2018	0.16	0.26 (68.27 %)	2018 Q2
12/31/2017	0.11	0.2 (83.52 %)	2017 Q4
6/30/2017	0.08	0.09 (4.07 %)	2017 Q2
6/30/2016	0.1	-0.01 (-107.65 %)	2016 Q2
12/31/2015	0.13	-0.14 (-207.26 %)	2015 Q4
6/30/2015	0.15	0.22 (44.65 %)	2015 Q2
12/31/2014	0.13	-0.01 (-110.07 %)	2014 Q4
6/30/2013	0.03	0.02 (-35.79 %)	2013 Q2
12/31/2012	0.07	-0 (-104.96 %)	2012 Q4
6/30/2012	0.04	0.06 (36.39 %)	2012 Q2
12/31/2011	0.15	-0.11 (-173.78 %)	2011 Q4
6/30/2011	0.36	0.18 (-48.87 %)	2011 Q2
12/31/2010	0.29	0.3 (4.85 %)	2010 Q4
6/30/2010	0.16	0.32 (96.36 %)	2010 Q2

%	Name	Stocks	Change	Date
45.91284 %	Heren Far East Ltd.	834,250,000	-64,000,000	9/21/2023
1.62955 %	Dimensional Fund Advisors, L.P.	29,609,500	-78,000	3/31/2024
1.52068 %	The Vanguard Group, Inc.	27,631,235	150,000	3/31/2024
0.89745 %	Tsoi (Hoi Shan)	16,306,875	0	11/30/2023
0.88210 %	Bosera Asset Management Co., Ltd.	16,028,000	3,912,000	12/31/2023
0.80802 %	Victory Capital Management Inc.	14,682,000	2,866,000	12/31/2023
0.72052 %	GF Fund Management Co., Ltd.	13,092,000	7,764,000	12/31/2023
0.70676 %	Goldman Sachs Asset Management, L.P.	12,842,000	0	2/29/2024
0.69201 %	Avantis Investors	12,574,000	114,000	3/31/2024
0.64589 %	Allianz Global Investors GmbH	11,735,937	-246,000	2/29/2024
0.62572 %	Norges Bank Investment Management (NBIM)	11,369,539	-591,319	12/31/2023
0.59394 %	BlackRock Institutional Trust Company, N.A.	10,792,000	-128,000	3/31/2024
0.44930 %	China Universal Asset Management Co., Ltd.	8,164,000	-2,930,000	12/31/2023
0.40032 %	Baillie Gifford & Co.	7,274,000	436,000	1/31/2024
0.34045 %	Nordea Investment Management AB (Denmark)	6,186,000	-28,000	2/29/2024
0.31228 %	Florida State Board of Administration	5,674,306	-879,793	9/30/2022
0.24986 %	China Asset Management Co., Ltd.	4,540,000	4,540,000	12/31/2023
0.21915 %	Artemis Investment Management LLP	3,982,000	0	12/31/2023
0.21023 %	MFS Investment Management	3,820,000	0	12/31/2023
0.16014 %	Charles Schwab Investment Management, Inc.	2,909,747	106,000	3/31/2024
0.15551 %	BlackRock Advisors (UK) Limited	2,825,649	58,000	3/31/2024
0.13831 %	California State Teachers Retirement System	2,513,106	74,000	6/30/2023
0.13340 %	Jupiter Asset Management Ltd.	2,424,000	510,000	12/31/2023
0.12933 %	Value Partners Ltd.	2,350,000	0	12/31/2023
0.11667 %	Nordea Funds Oy	2,120,000	0	2/29/2024
0.11546 %	1832 Asset Management L.P.	2,098,000	0	12/31/2023
0.11248 %	RAM Active Investments S.A.	2,043,862	-177,563	12/31/2023
0.10875 %	AllianceBernstein L.P.	1,976,000	0	2/29/2024
0.10611 %	Fullgoal Fund Management Co., Ltd.	1,928,000	34,000	12/31/2023
0.10547 %	State Street Global Advisors (US)	1,916,500	-50,000	3/31/2024
0.10221 %	E Fund Management Co. Ltd.	1,857,209	1,818,424	12/31/2023
0.09287 %	Dimensional Fund Advisors, Ltd.	1,687,500	34,000	1/31/2024
0.08938 %	JPMorgan Asset Management U.K. Limited	1,624,000	680,000	2/29/2024
0.08596 %	SEI Investments Management Corporation	1,561,955	-656,995	3/31/2024
0.07991 %	AXA Investment Managers UK Ltd.	1,452,000	0	2/29/2024
0.07055 %	East Capital Asset Management AB	1,282,000	1,282,000	2/29/2024
0.06384 %	Penghua Fund Management Co., Ltd.	1,160,000	1,160,000	12/31/2023
0.05878 %	LähiTapiola Varainhoito Oy	1,068,000	62,000	1/31/2024
0.05779 %	Goldman Sachs Asset Management International	1,050,000	0	12/31/2023
0.04920 %	Thrivent Asset Management, LLC	894,000	0	1/31/2024
0.04825 %	China Asset Management (Hong Kong) Limited	876,784	-52,000	3/31/2024
0.04491 %	Lazard Asset Management, L.L.C.	816,000	0	1/31/2024
0.04359 %	China Merchants Fund Management Co. Ltd.	792,000	308,000	12/31/2023
0.04249 %	LSV Asset Management	772,000	0	12/31/2023
0.04103 %	Nuveen LLC	745,562	0	3/31/2024
0.04073 %	American Century Investment Management, Inc.	740,000	6,000	3/31/2024
0.03775 %	Geode Capital Management, L.L.C.	686,000	0	2/29/2024
0.03643 %	HuaAn Fund Management Co., Ltd.	662,000	636,000	12/31/2023
0.03302 %	Parametric Portfolio Associates LLC	600,000	0	12/31/2023
0.03115 %	UBS Asset Management (UK) Ltd.	566,000	40,000	3/31/2024
0.03016 %	China Southern Asset Management Co. Ltd.	548,000	548,000	12/31/2023
0.02763 %	Credit Suisse Funds AG	502,000	0	2/29/2024
0.02741 %	Margetts Fund Management Limited	498,000	498,000	12/31/2023
0.02355 %	Yinhua Fund Management Co., Ltd.	428,000	428,000	12/31/2023
0.02077 %	Eika Kapitalforvaltning AS	377,402	0	1/31/2024
0.02069 %	ICBC Credit Suisse Asset Management Co. Ltd.	376,000	376,000	6/30/2023
0.01981 %	Asset Management One Co., Ltd.	360,000	-322,000	11/30/2023
0.01849 %	State Street Global Advisors (Japan) Co., Ltd.	336,000	0	2/29/2024
0.01728 %	Segall Bryant & Hamill, LLC	314,000	-60,223	2/29/2024
0.01596 %	KLP Fondsforvaltning AS	290,000	130,000	2/29/2024
0.01541 %	Zürcher Kantonalbank (Asset Management)	280,000	0	1/31/2024
0.01533 %	Russell Investments Limited	278,520	-984	2/29/2024
0.01530 %	Northern Trust Global Investments Limited	278,000	0	12/31/2023
0.01475 %	JPMorgan Asset Management (China) Company Limited.	268,000	192,000	12/31/2023
0.01431 %	BlackRock Investment Management (UK) Ltd.	260,000	0	12/31/2023
0.01387 %	WCM Investment Management	252,000	16,000	12/31/2023
0.01342 %	BlackRock Asset Management Canada Limited	243,810	0	3/31/2024
0.01299 %	Handelsbanken Kapitalförvaltning AB	236,000	-46,000	2/29/2024
0.01222 %	Acadian Asset Management LLC	222,000	0	2/29/2024
0.01148 %	Fidelity International	208,636	16,231	2/29/2024
0.01142 %	Vanguard Investments Australia Ltd.	207,452	-43	2/29/2024
0.01127 %	Invesco Capital Management LLC	204,830	-6,590	2/29/2024
0.01112 %	Credit Suisse Asset Management (Schweiz) AG	202,000	0	3/31/2024
0.01101 %	Zou (Xian Hong)	200,000	0	11/29/2023
0.01068 %	Mercer Global Investments Management Ltd	194,000	0	3/31/2024
0.00991 %	Simplicity AB	180,000	0	3/31/2024
0.00837 %	Allianz Global Investors Asia Pacific Limited	152,000	0	2/29/2024
0.00682 %	State Street Global Advisors Ireland Limited	124,000	0	3/31/2024
0.00678 %	DFA Australia Ltd.	123,200	207	12/31/2023
0.00649 %	Choy (Siu Chit)	117,875	0	11/30/2023
0.00616 %	Huatai-PineBridge Fund Management Co., Ltd.	112,000	-28,000	6/30/2023
0.00528 %	Legal & General Investment Management Ltd.	96,000	0	2/29/2024
0.00528 %	AXA Investment Managers Paris	96,000	20,000	10/31/2023
0.00485 %	DWS Investment GmbH	88,115	0	12/31/2023
0.00462 %	Lingohr & Partner Asset Management GmbH	84,000	0	1/31/2024
0.00429 %	Guliver Anlageberatung GmbH	78,000	0	1/31/2024
0.00396 %	Samsung Asset Management Co., Ltd.	72,000	72,000	9/30/2023
0.00363 %	Allspring Global Investments, LLC	66,000	0	2/29/2024
0.00297 %	Union Investment Privatfonds GmbH	54,000	0	9/30/2023
0.00286 %	Vanguard Global Advisers LLC	52,000	0	3/31/2024
0.00275 %	Artico Partners AG	50,000	-10,000	3/31/2024
0.00275 %	AcomeA SGR S.p.A.	50,000	0	12/31/2023
0.00231 %	INVESCO Great Wall Fund Management Co. Ltd.	42,000	12,000	12/31/2023
0.00226 %	Finlabo SIM S.p. A.	41,000	0	2/29/2024
0.00219 %	Cinda Fund Management Co., Ltd.	39,796	-204	12/31/2023
0.00209 %	Pictet Asset Management Ltd.	38,000	0	11/30/2023
0.00198 %	Russell Investments Japan Co., Ltd.	36,000	-6,476	8/31/2023
0.00187 %	JP Morgan Asset Management	34,000	-2,000	2/29/2024
0.00176 %	First Trust Advisors L.P.	32,000	0	2/29/2024
0.00170 %	HSBC Global Asset Management (UK) Limited	30,978	0	1/31/2024

What values and corporate philosophy does United Laboratories International Holdings represent?

United Laboratories International Holdings Ltd represents a strong commitment to innovation, quality, and customer satisfaction. The company's corporate philosophy revolves around delivering cutting-edge solutions and services to meet the evolving needs of its clients. United Laboratories International Holdings Ltd places great emphasis on integrity, professionalism, and ethical business practices, ensuring the highest standards across all operations. With a focus on research and development, United Laboratories International Holdings Ltd strives to provide top-tier pharmaceutical and healthcare products that improve the well-being of individuals worldwide. This dedication to excellence and customer-centric approach makes United Laboratories International Holdings Ltd a trusted leader in the industry.

In which countries and regions is United Laboratories International Holdings primarily present?

United Laboratories International Holdings Ltd is primarily present in various countries and regions. This global pharmaceutical company has a strong presence in the United States, China, Europe, Southeast Asia, and South Africa. With a focus on research and development, United Laboratories International Holdings Ltd has established a robust network in these regions, allowing it to deliver high-quality healthcare products and services. By expanding its reach across different markets, the company aims to meet the diverse needs of patients and healthcare professionals worldwide.

What significant milestones has the company United Laboratories International Holdings achieved?

United Laboratories International Holdings Ltd has achieved several significant milestones throughout its history. These milestones include expanding its product portfolio, establishing a strong global presence, and delivering innovative healthcare solutions to millions of people worldwide. The company has successfully launched numerous groundbreaking pharmaceutical and healthcare products, ensuring access to quality healthcare for patients around the globe. Through strategic partnerships and continuous research and development, United Laboratories International Holdings Ltd has consistently demonstrated its commitment to improving the well-being of individuals and communities. These achievements have cemented the company's position as a leader in the healthcare industry.

What is the history and background of the company United Laboratories International Holdings?

United Laboratories International Holdings Ltd, commonly known as United Labs, is a renowned pharmaceutical company with a rich history and extensive background. Founded in [insert year], United Labs has emerged as a global leader in the research, development, and manufacturing of innovative healthcare solutions. With a strong emphasis on cutting-edge technology and a dedicated team of experts, the company has consistently delivered high-quality pharmaceutical products that meet stringent international standards. United Labs has a broad product portfolio encompassing various therapeutic areas, including [mention specific areas]. Over the years, the company has expanded its presence globally, establishing strategic partnerships and subsidiaries, thus cementing its position as an industry leader in the pharmaceutical sector.

Who are the main competitors of United Laboratories International Holdings in the market?

The main competitors of United Laboratories International Holdings Ltd in the market include big players such as Pfizer Inc., Johnson & Johnson, and Novartis AG. These companies are renowned pharmaceutical giants that compete with United Laboratories International Holdings Ltd in terms of product offerings, market share, and global reach.

In which industries is United Laboratories International Holdings primarily active?

United Laboratories International Holdings Ltd is primarily active in the pharmaceutical and healthcare industries.

What is the business model of United Laboratories International Holdings?

The business model of United Laboratories International Holdings Ltd (ULI) revolves around the development, manufacturing, and sale of generic and branded pharmaceutical products. As one of the leading pharmaceutical companies in the Asia Pacific region, ULI aims to provide affordable and high-quality healthcare solutions to patients worldwide. With a focus on research and development, ULI continuously strives to innovate and introduce new products to meet the evolving needs of its customers. By adhering to rigorous quality standards and maintaining strong relationships with healthcare professionals, ULI aims to achieve sustainable growth and contribute to the betterment of global healthcare.

What is the P/E ratio of United Laboratories International Holdings 2024?

The United Laboratories International Holdings P/E ratio is 6.18.

What is the P/S ratio of United Laboratories International Holdings 2024?

The United Laboratories International Holdings P/S ratio is 1.19.

What is the Quality Investing of United Laboratories International Holdings?

The Quality Investing for United Laboratories International Holdings is 8/10.

What is the revenue of United Laboratories International Holdings 2024?

The expected United Laboratories International Holdings revenue is 14.94 B CNY.

How high is the profit of United Laboratories International Holdings 2024?

The expected United Laboratories International Holdings profit is 2.88 B CNY.

What is the business model of United Laboratories International Holdings

United Laboratories International Holdings Ltd (ULIH) is a globally operating company in the chemical and pharmaceutical industry based in Hong Kong. The company offers a wide range of chemical and pharmaceutical products and manufactures them in various divisions distributed worldwide. ULIH's business model is based on comprehensive research and development work that enables the company to produce innovative products that meet customer needs. The pharmaceutical and chemical industry is one of the most important sectors of the global economy today. It is highly dependent on technological developments and investments in research and development. ULIH's position in the global market is supported by offering a variety of high-quality products divided into different categories such as chemical raw materials, semi-finished products, pharmaceuticals, and health products. ULIH produces and distributes raw materials for pharmaceutical production. Such specialty products are often needed in small quantities, making this product segment an important part of the business. The products include medical gases, API (Active Pharmaceutical Ingredients), and injection fluids, among others. In the production of semi-finished products, the company utilizes various technologies and produces targeted active ingredients, cephalosporins, and steroids, for example. In the field of pharmaceuticals, ULIH offers a wide range of medical products such as antibiotics, anti-tuberculosis drugs, analgesics, anti-rheumatics, and others. Some of the well-known products include chloramphenicol and itraconazole. The company's stated goal is to further expand and optimize its medical products to improve the health and well-being of patients worldwide. Another important business area for ULIH is the offering of health products. The offered products include nutritional supplements, herbal extracts, and other products that can contribute to improving the health and well-being of consumers. The company is also committed to a sustainable business model that focuses on environmental aspects, employees, and the common good. It strives to minimize CO2 emissions and create socially responsible working conditions. The brand is valued in many countries around the world and stands out for its quality and customer satisfaction. In summary, ULIH offers a wide range of products and services tailored to the needs of pharmaceutical and chemical companies, health product manufacturers, and end consumers. The business model is focused on continuous improvement and innovation and seeks long-term customer relationships and partnerships.

What is the United Laboratories International Holdings dividend?

United Laboratories International Holdings pays a dividend of 0.15 CNY distributed over payouts per year.

How often does United Laboratories International Holdings pay dividends?

The dividend cannot currently be calculated for United Laboratories International Holdings or the company does not pay out a dividend.

What is the United Laboratories International Holdings ISIN?

The ISIN of United Laboratories International Holdings is KYG8813K1085.

What is the United Laboratories International Holdings WKN?

The WKN of United Laboratories International Holdings is A0MUFS.

What is the United Laboratories International Holdings ticker?

The ticker of United Laboratories International Holdings is 3933.HK.

How much dividend does United Laboratories International Holdings pay?

Over the past 12 months, United Laboratories International Holdings paid a dividend of 0.28 CNY . This corresponds to a dividend yield of about 2.9 %. For the coming 12 months, United Laboratories International Holdings is expected to pay a dividend of 0.32 CNY.

What is the dividend yield of United Laboratories International Holdings?

The current dividend yield of United Laboratories International Holdings is 2.9 %.

When does United Laboratories International Holdings pay dividends?

United Laboratories International Holdings pays a quarterly dividend. This is distributed in the months of October, July, August, October.

How secure is the dividend of United Laboratories International Holdings?

United Laboratories International Holdings paid dividends every year for the past 9 years.

What is the dividend of United Laboratories International Holdings?

For the upcoming 12 months, dividends amounting to 0.32 CNY are expected. This corresponds to a dividend yield of 3.25 %.

In which sector is United Laboratories International Holdings located?

United Laboratories International Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von United Laboratories International Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of United Laboratories International Holdings from 10/15/2024 amounting to 0.176 CNY, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did United Laboratories International Holdings pay the last dividend?

The last dividend was paid out on 10/15/2024.

What was the dividend of United Laboratories International Holdings in the year 2023?

In the year 2023, United Laboratories International Holdings distributed 0.15 CNY as dividends.

In which currency does United Laboratories International Holdings pay out the dividend?

The dividends of United Laboratories International Holdings are distributed in CNY.

Stock Exchange	United Laboratories International Holdings Ticker
FRANKFURT	UNJ.F
HKSE	3933.HK
MUNICH	UNJ.MU
PNK	ULIHF

United Laboratories International Holdings Ticker	United Laboratories International Holdings FIGI
3933:HK	BBG000JZ6DW1
UNJ:GR	BBG000RHK0F3
UNJ:GF	BBG000RHK0Y2
UNJ:GS	BBG000RHK1S7
UNJ:GM	BBG000RHK232
UNJ:GB	BBG000RHK2K3
ULIHF:US	BBG001KBT5W2
ULIHF:PQ	BBG001KBT696
ULIHF:UV	BBG001KBT6C2
3933:H2	BBG00F136127
3933HKD:X2	BBG00JQDPJN7
3933HKD:XB	BBG00JQDPJP5
3933HKD:XH	BBG00JQDPJR3
3933HKD:XF	BBG00JQDPJT1
3933HKD:XE	BBG00JQDPJW7
3933HKD:XJ	BBG00JQDPJX6
3933HKD:XL	BBG00JQDPJY5
3933HKD:XG	BBG00JQDPJZ4
3933HKD:XO	BBG00JQDPK09
3933HKD:XS	BBG00JQDPK45
3933HKD:XA	BBG00JQDPK54
3933HKD:E1	BBG00JQDPK63
3933HKD:XT	BBG00JQDPK72
3933HKD:XW	BBG00JQDPK81
3933HKD:XU	BBG00JQDPK90
3933HKD:XV	BBG00JQDPKB7
3933HKD:XM	BBG00JQDPKC6
3933HKD:XQ	BBG00JQDPKF3
3933HKD:XX	BBG00JQDPKG2
3933HKD:XZ	BBG00JQDPKH1
3933HKD:EU	BBG00JQDPKK7
3933HKD:EP	BBG00TDD00N7
3933HKD:EZ	BBG00TDD00Q4
UNJ:GZ	BBG011XLTQ22
3933EUR:XH	BBG011XLW2R4
3933EUR:XF	BBG011XLW2T2
3933EUR:XE	BBG011XLW2W8
3933EUR:XL	BBG011XLW2Y6
3933EUR:XG	BBG011XLW2Z5
3933EUR:XO	BBG011XLW301
3933EUR:XA	BBG011XLW347
3933EUR:XT	BBG011XLW365
3933EUR:XW	BBG011XLW374
3933EUR:XU	BBG011XLW383
3933EUR:XV	BBG011XLW3B9
3933EUR:XM	BBG011XLW3C8
3933EUR:EU	BBG011XLW3L8
UNJ:LA	BBG018H8PSP9
UNJ:LU	BBG018J2BTS0
3933:H1	BBG01FRSSB09

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
1.28	1.81	2.13	2.53	3.35	4.09	5.67	5.32	5.71	6.06	7.19	6.74	6.08	6.83	7.51	8.39	8.77	9.7	11.33	13.74	14.94	15.48	16.33
-	42.04	17.84	18.51	32.54	22.05	38.47	-6.14	7.39	6.15	18.61	-6.23	-9.85	12.33	10.02	11.74	4.53	10.61	16.81	21.22	8.72	3.66	5.46
33.18	34.84	35.38	46.46	38.04	39.06	39.49	28.55	30.16	34.48	40.20	38.48	35.58	36.60	40.64	43.15	43.39	43.40	43.83	46.10	-	-	-
0.42	0.63	0.76	1.18	1.28	1.6	2.24	1.52	1.72	2.09	2.89	2.59	2.16	2.5	3.05	3.62	3.81	4.21	4.97	6.33	0	0	0
0.21	0.24	0.31	0.61	0.56	0.71	1.08	0.28	0.32	0.41	1.29	0.74	0.41	0.69	1.01	1.08	1.25	1.16	2.11	3.28	3.57	3.5	3.66
16.63	13.42	14.29	24.24	16.68	17.26	18.98	5.19	5.52	6.75	17.96	10.99	6.71	10.09	13.38	12.87	14.25	11.94	18.58	23.88	23.87	22.62	22.41
0.14	0.12	0.18	0.5	0.38	0.48	0.85	0.09	0.13	0.04	0.61	0.1	-0.27	0.08	0.68	0.64	0.7	0.99	1.58	2.7	2.88	2.85	3
-	-12.86	45.90	179.21	-22.94	24.54	77.78	-89.86	52.33	-70.99	1,502.63	-84.24	-383.33	-129.78	741.98	-6.01	9.52	40.74	60.02	70.84	6.44	-0.77	5.29
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.98	0.98	0.98	1.16	1.31	1.31	1.36	1.44	1.51	1.63	1.63	1.63	1.63	1.63	1.83	1.64	1.77	1.84	1.82	1.82	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

Ticker3933.HK

ISINKYG8813K1085

WKNA0MUFS

United Laboratories International Holdings stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

United Laboratories International Holdings Stock Price History

United Laboratories International Holdings Revenue, EBIT, Net Income KYG8813K1085 · A0MUFS

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

United Laboratories International Holdings Revenue, EBIT and net profit per share

United Laboratories International Holdings Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

United Laboratories International Holdings stock margins KYG8813K1085 · A0MUFS

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

United Laboratories International Holdings Margin History

United Laboratories International Holdings Stock Sales Revenue, EBIT, Earnings per Share KYG8813K1085 · A0MUFS

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

United Laboratories International Holdings Revenue, EBIT and net profit per share

United Laboratories International Holdings business model

United Laboratories International Holdings SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

United Laboratories International Holdings Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

United Laboratories International Holdings historical P/E ratio, EBIT multiple, and P/S ratio

United Laboratories International Holdings shares outstanding KYG8813K1085 · A0MUFS

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

United Laboratories International Holdings dividend history and estimates KYG8813K1085 · A0MUFS

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

United Laboratories International Holdings Dividend History

United Laboratories International Holdings dividend payout ratio KYG8813K1085 · A0MUFS

Payout ratio

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
3933.HK

ISIN
KYG8813K1085

WKN
A0MUFS